EFV | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

EFV
Australia

With Fermion, start the journey of your innovative API.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

pharmacompass-1-m-2026-03-23

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2026-03-23

EFV

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 28 USDMF, 8 EU WC, 2 KDMF, 16 NDC API, 19 Listed Suppliers, $ API Reference Price

50 API Suppliers
28 USDMF
8 EU WC
2 KDMF
16 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

252 FDF Dossiers, 59 FDA Orange Book, 94 Europe, 8 Canada, 2 Australia, 68 South Africa, 21 Listed Dossiers

252 FDF Dossiers
59 FDA Orange Book
94 Europe
8 Canada
2 Australia
68 South Africa
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG;300MG;300MG, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 400MG;300MG;300MG
CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 600MG;200MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 1 Finar, 7 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 21 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 32 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 20 Granulation, 16 Thickeners and Stabilizers, 16 Lubricants & Glidants, 15 Direct Compression, 11 Topical, 9 Co-Processed Excipients, 9 Empty Capsules, 7 Film Formers & Plasticizers, 6 Taste Masking, 5 Solubilizers, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 Parenteral, 2 Coloring Agents, 1 Surfactant & Foaming Agents

45 Coating Systems & Additives
32 Fillers, Diluents & Binders
23 Controlled & Modified Release
22 Disintegrants & Superdisintegrants
20 Granulation
16 Thickeners and Stabilizers
16 Lubricants & Glidants
15 Direct Compression
11 Topical
9 Co-Processed Excipients
9 Empty Capsules
7 Film Formers & Plasticizers
6 Taste Masking
5 Solubilizers
5 API Stability Enhancers
4 Emulsifying Agents
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
3 Rheology Modifiers
3 Parenteral
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

55 News #PharmaBuzz

55 News #PharmaBuzz

GLOBAL SALES INFORMATION

17 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 15 Annual Reports

17 US Medicaid Prescriptions
12 Regulatory FDF Prices
15 Annual Reports

MARKET PLACE

9 APIs, 5 FDF Dossiers

9 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 18 Health Canada Patents

5 US Patents
18 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 9 Others

4 USP
9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 214 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 1Alphapharm Pty Ltd

02 1Pro Pharmaceuticals Group Pty. Ltd.

filter Active Ingredients Reset all filters

2 All

01 2tenofovir disoproxil + emtricitabine + efavirenz

filter Dosage Form Reset all filters

2 All

01 1Tablet

02 1Blank

filter Brand Name Reset all filters

2 All

01 1Efavirenz, Emtricitabine and Tenofovir Disopr

02 1Tenofovir Disoproxil Emtricitabine Efavirenz

List of Suppliers

Product Main Page

01

Alphapharm Pty Ltd

CGT Asia

Not Confirmed

Alphapharm Pty Ltd

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine + efavirenz

Brand Name : Tenofovir Disoproxil Emtricitabine Efavirenz

Dosage Form : Tablet

Dosage Strength : 300MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Pro Pharmaceuticals Group Pty. Ltd.

CGT Asia

Not Confirmed

Pro Pharmaceuticals Group Pty. Ltd.

CGT Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

tenofovir disoproxil + emtricitabine + efavirenz

Brand Name : Efavirenz, Emtricitabine and Tenofovir Disopr

Dosage Form :

Dosage Strength :

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.